-
公开(公告)号：EP2190415A2
公开(公告)日：2010-06-02
申请号：EP08789518.1
申请日：2008-08-01
IPC分类号： A61K9/20
CPC分类号： A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2059 , A61K9/2077 , A61K9/2095 , A61K31/216
摘要： The invention relates to pharmaceutical compositions comprising non-micronized fenofibrate with one or more pharmaceutically acceptable vehicles. The invention also relates to pharmaceutical compositions comprising non-micronized fenofibrate with one or more cyclodextrin derivatives. The invention also relates to processes for the preparation of such compositions.
-
公开(公告)号：EP2148655A2
公开(公告)日：2010-02-03
申请号：EP08737878.2
申请日：2008-04-16
申请人： Wockhardt Research Centre , Ujjainkar, Amol , Balla Pattabhi, Srinivas , Khan, Abdul Rehman , Murali, Narayanan , Jain, Girish Kumar
发明人： UJJAINKAR, Amol , BALLA PATTABHI, Srinivas , KHAN, Abdul Rehman , MURALI, Narayanan , JAIN, Girish Kumar
CPC分类号： A61K31/4365 , A61K9/1652 , A61K9/2009 , A61K9/2013 , A61K9/2054 , A61K9/2077 , A61K9/284 , A61K9/2866
摘要： The invention relates to pharmaceutical compositions comprising clopidogrel or monobasic acid salts thereof in admixture with one or more hydrated excipients. The invention also relates to pharmaceutical compositions comprising clopidogrel or monobasic acid salts thereof which are free of any moisture scavenger. The invention also relates to processes for the preparation of such compositions.
-
公开(公告)号：EP2142175A2
公开(公告)日：2010-01-13
申请号：EP08737625.7
申请日：2008-03-25
申请人： Wockhardt Research Centre , Gundu, Ramakant , Jain, Girish Kumar , Murali, Narayanan , Dabre, Rahul , Kodgule, Mandar
IPC分类号： A61K9/20 , A61K31/5575 , A61K31/196 , A61P15/00
CPC分类号： A61K31/5575 , A61K9/1676 , A61K9/2072 , A61K9/2077 , A61K9/2081 , A61K9/209 , A61K9/5026 , A61K9/5078 , A61K9/5084 , A61K31/196 , A61K2300/00
摘要： The present invention relates to pharmaceutical compositions of diclofenac or pharmaceutically acceptable salts thereof and misoprostol or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparations of such compositions.
-
4.发明公开SINGLE UNIT ORAL DOSE PHARMACEUTICAL COMPOSITION COMPRISING LEVODOPA, CARBIDOPA AND ENTACAPONE OR SALTS THEREOF 无效与左旋多巴，卡比多巴和恩他卡朋或其盐单次口服药物组合物
公开(公告)号：EP2326311A1
公开(公告)日：2011-06-01
申请号：EP09786997.8
申请日：2009-08-22
IPC分类号： A61K9/20 , A61K31/198 , A61K45/06 , A61P25/16
CPC分类号： A61K45/06 , A61K9/2059 , A61K9/209 , A61K31/198 , A61K31/277 , A61K2300/00
摘要： There is provided a single unit oral dose pharmaceutical composition comprising a) levodopa or salts thereof from about 50 mg to about 300 mg in extended release form, b) carbidopa or salts thereof from about 10 mg to about 100 mg in extended release and c) entacapone or salts thereof from about 100 mg to about 1000 mg in immediate release form, optionally with other pharmaceutically acceptable excipients. The invention also relates to process of preparation of such compositions.
-
公开(公告)号：EP2150242A2
公开(公告)日：2010-02-10
申请号：EP08737923.6
申请日：2008-04-19
申请人： Wockhardt Research Centre , Jain, Girish Kumar , Kandi, Chandrashekhar Shriram , Nande, Vishwanath
IPC分类号： A61K9/28 , A61K9/48 , A61K9/50 , A61K31/381
CPC分类号： A61K9/2886 , A61K9/2027 , A61K9/2059 , A61K9/2846 , A61K9/2866 , A61K9/4808 , A61K9/4891 , A61K9/5026 , A61K9/5047 , A61K9/5073 , A61K9/5078 , A61K31/381 , A61K47/585
摘要： The present invention relates to pharmaceutical compositions of duloxetine or pharmaceutically acceptable salts thereof, and processes for their preparation.
-
公开(公告)号：EP2167048A2
公开(公告)日：2010-03-31
申请号：EP08737626.5
申请日：2008-03-25
IPC分类号： A61K9/20
CPC分类号： A61K9/2886 , A61K9/2072 , A61K9/209 , A61K31/196 , A61K31/40 , A61K31/4184 , A61K31/4418 , A61K31/4422 , A61K31/55 , A61K31/557 , A61K31/5575 , A61K45/06 , A61K2300/00
摘要： The present invention relates to novel tablet dosage forms and methods of preparing these forms, which can be used for different classes of pharmaceutical active ingredients posing stability issues in a single unit system. The dosage form includes a first layer, which includes a tablet of one or more active pharmaceutical ingredients, which is inlayed in the first layer along with other pharmaceutically acceptable excipients, and a second layer that includes one or more active pharmaceutical ingredients optionally with other pharmaceutically acceptable excipients.
-
7.发明公开
公开(公告)号：EP2293791A1
公开(公告)日：2011-03-16
申请号：EP09708991.6
申请日：2009-02-06
IPC分类号： A61K31/275 , A61K9/14 , A61K47/26 , A61K9/16 , A61K9/26
CPC分类号： A61K9/145 , A61K9/1635 , A61K9/2018 , A61K9/2027 , A61K31/275
摘要： The present invention relates to pharmaceutical compositions comprising entacapone or pharmaceutically acceptable salts thereof along with one or more sugar alcohols; wherein the entacapone is co-micronized with one or more sugar alcohols. The invention also relates to processes of making such compositions.
摘要翻译： 本发明涉及包含恩他卡朋或其药学上可接受的盐以及一种或多种糖醇的药物组合物; 其中恩他卡朋与一种或多种糖醇共微粉化。 本发明还涉及制造这种组合物的方法。
-
公开(公告)号：EP2268268A2
公开(公告)日：2011-01-05
申请号：EP08807816.7
申请日：2008-09-26
发明人： TALWAR, Munish , DABRE, Rahul , KAPOOR, Ritesh , VERMA, Himanshu , JAIN, Nitin , JAIN, Girish Kumar
CPC分类号： A61K9/0056 , A61K9/2054 , A61K9/7007 , A61K31/192 , A61K31/235
摘要： The invention relates to orally disintegrating pharmaceutical compositions comprising rhein or diacerein, or salts or esters or prodrugs thereof, and processes for preparing such compositions.
-
公开(公告)号：EP2114374A2
公开(公告)日：2009-11-11
申请号：EP07866569.2
申请日：2007-12-20
申请人： Wockhardt Research Centre , Kalantri, Mahesh Rameshwar , Goswami, Sudhir , Murali, Narayanan , Jain, Girish Kumar
IPC分类号： A61K9/14
CPC分类号： A61K9/2095 , A61K9/2018 , A61K9/2054
摘要： The invention relates to pharmaceutical compositions comprising entacapone or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparation of such compositions.
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.009 秒)
